Contrarian Sales Techniques

DECEMBER 30, 2023

This blog post is your road map to crushing your sales goals in 2024, even if the economic weather looks stormy. 2024, like every new year, promises a cornucopia of possibilities, but whispers of economic uncertainty hang heavy in the air. Hold onto your hats, my fellow sales voyagers, because I say choose the latter.

Sales 52

Sales Customer Relationship Management Engineering Media 52

Contrarian Sales Techniques

DECEMBER 31, 2023

Highlights of the Year 2023 has been a transformative year in the world of sales, marked by significant advancements and innovations. On this blog, we've explored and implemented cutting-edge sales strategies and techniques that have redefined how we approach selling.

Sales 64

Sales Ethics Sales Strategy Media 64

Fierce Pharma

DECEMBER 13, 2023

Using Tuesday to announce good news—that its $43 billion acquisition of Seagen would be | Using Tuesday to announce good news—that its $43 billion acquisition of Seagen would be finalized on Thursday—Pfizer sandwiched its bad news, which came on Wednesday with its 2024 guidance. The company expects revenue to reach between $58.5

Sales 346

Sales 346

PM360

FEBRUARY 23, 2024

A Gold, Silver, and Bronze winner is named based on the top three vote-earners in each of the 14 categories, including: App, Consumer Website, DTC/DTP, Multichannel, Multicultural, Philanthropic, Professional Campaign (Print), Professional Website, Sales Aid, Self-Promotion/Corporate Campaign, Social Media, Unbranded, Variety, and Video.

Pharma 52

Pharma Media Sales Healthcare 52

Fierce Pharma

JANUARY 3, 2024

Morgan Healthcare Conference rolled on in San Francisco, BioNTech, Alnylam and many other companies updated investors on their strategies heading into 2024. As the J.P. | As the J.P.

Biopharma 285

Biopharma Sales Healthcare Healthcare 285

Quantified

DECEMBER 5, 2023

If your business has been around long enough, you likely remember the days of sales in the field, knocking on doors and pounding pavement to drum up leads. Over the years, however, there have been innovations and transformations in how your sales teams cold call, nurture, present to, and close new customers.

Sales 52

Sales Training Sales process Sales Management 52

Fierce Pharma

FEBRUARY 28, 2024

The company is eying four new indications and potential peak sales of 4 billion euros. After a busy 2023 marked by multiple drug approvals, UCB isn’t resting on its laurels. After an initial FDA approval came later than anticipated, UCB is looking to quickly grow Bimzelx.

FDA 226

FDA Sales 226

Fierce Pharma

NOVEMBER 6, 2023

The drug launched after an FDA approval in May 2023.

Sales 247

Sales FDA 247

Fierce Pharma

MARCH 19, 2024

In moments of great uncertainty, sometimes the best approach is to just press on. CDMO WuXi AppTec reported solid performance in 2023 and expects good things for the coming year, too. Still, the Chinese contract manufacturer finds itself embroiled in a national security crackdown in the U.S.,

Manufacturing 216

Manufacturing Sales 216

Contrarian Sales Techniques

FEBRUARY 13, 2024

So, you've got your sights set on the pharmaceutical sales world for 2024, huh? Why choose pharma sales job? Breaking into pharma sales is like trying to get backstage at a sold-out concert (think Cold Play for Malaysians). Details on the difference between Medical Devices sales to Pharma sales ) Your toolkit?

Pharmaceutical Sales 52

Pharmaceutical Sales Pharma sales reps Sales Pharmaceutical 52

Quantified

MARCH 5, 2024

Most sales organizations have a sales forecast accuracy of less than 75%. Poor forecasts hurt almost every part of the sales team—from the sales managers who choose goals and priorities to the sales reps who are striving for impossible goals to the clients who are hit with rushed and desperate pitches.

Sales 52

Sales Leads Training Prospecting 52

Fierce Pharma

JANUARY 3, 2024

Plus, Moderna, bluebird and other companies updated investors on their businesses heading into 2024. Morgan Healthcare Conference kicked off in San Francisco, EY released its annual report on the industry's dealmaking firepower.

Healthcare 267

Healthcare Healthcare Sales 267

Fierce Pharma

JANUARY 31, 2024

billion in sales in 2023 compared to $890 million for Pfizer's Abrysvo. But the British pharma major says that the successful launch represents just one round of a boxing match, and much is still to be decided, especially with Moderna expected to join the battle in 2024.

Pharma 298

Pharma Sales 298

Fierce Pharma

FEBRUARY 15, 2024

With the company revealing fourth-quarter sales of $56.2 million for Lybalvi, the olanzapine and samidorphan treatment is continuing its upward trajectory, helping trigger a 10% increase in the company's shares.

Sales 200

Sales 200

PM360

FEBRUARY 23, 2024

Pacific Communications, Indegene, and Allergan, an AbbVie company OZURDEX® Interactive Sales Aid We tackled this on two fronts. The first was a total redesign to modernize our look and feel and develop clean layouts. The second was ensuring UI and content delivered an intuitive experience.

Sales 52

Sales Pharma Management Marketing 52

Medical Sales Guru

JANUARY 2, 2024

The role of a medical sales representative involves navigating intricate dynamics with healthcare professionals. Consequently, many representatives opt to play it safe , fearing potential alienation that might hinder future sales opportunities. For more details about the complimentary masterclass and FREE registration, visit [link].

Medical 130

Medical Medical sales Sales Healthcare 130

Fierce Pharma

SEPTEMBER 27, 2023

Viatris just notched a win on its quest to reach $1 billion in eye care sales by 2028. | in the first half of 2024. The FDA on Wednesday approved Viatris and Ocuphire’s Ryzumvi, also known as phentolamine ophthalmic solution, to treat pharmacologically-induced mydriasis, or dilation of the pupils.

Pharmacology 240

Pharmacology FDA Sales 240

Clarivate

JANUARY 19, 2024

While the unknowns of AI are top of mind, there are many variables in the IP legal industry projected to influence 2024. Establishing a strategic plan for 2024 requires IP leaders to place their bets on which of these trends will most likely impact patents and trademarks this year. This will be a game-changer.”

Management 59

Management Consulting Professional Services Sales 59

Fierce Pharma

AUGUST 28, 2023

It’s a sale. The deal is expected to close in mid-2024. The deal is expected to close in mid-2024. Two months after Abcam launched a strategic review of the company, the British antibody research expert has revealed that it’s being bought by Danaher.

Sales 245

Sales 245

Contrarian Sales Techniques

APRIL 9, 2024

As the moon heralds the arrival of Eidul Fitr this April, it's not just a celebration marking the end of Ramadan, but a moment of reflection and gratitude for the journey we've embarked upon in 2024. The first quarter of 2024 has been a rollercoaster, presenting both hurdles and triumphs.

Marketing 52

Marketing 52

Clarivate

JANUARY 8, 2024

The annual Clarivate Drugs to Watch report for 2024 features 13 new therapeutics with standout commercial and/or clinical potential. Clarivate data indicates a 90% probability that datopotamab deruxtecan will win marketing authorization in the United States, and projects 2029 sales of $2.7 billion for NSCLC and breast cancer combined.

Marketing 59

Marketing Patients Healthcare Healthcare 59

PM360

JUNE 23, 2023

Press Release Contact: Kayla Walsh Awards Coordinator, PM360 646-300-8114 kayla.walsh@pm360online.com PM360 Now Accepting Entries for 2024 Pharma Choice Awards Call for the Best Healthcare Creative from the Past Year NEW YORK, NY, June 22, 2023 : The 2024 PM360 Pharma Choice Awards are officially open for entries.

Pharma 52

Pharma Marketing Healthcare Healthcare 52

Pharmaceutical Technology

FEBRUARY 21, 2023

Pfizer and BioNTech’s Covid-19 vaccine, Comirnaty, had a phenomenal year with forecast sales of $37bn in 2022. Comirnaty is the leading prophylactic vaccine for Covid-19 and is expected to generate an additional $2.8bn in sales in 2022 compared to GlobalData’s H1 2022 forecast. Comirnaty is the first globally approved Covid-19 vaccine.

Sales 98

Sales Government Leads Medicine 98

Spotio

JANUARY 4, 2024

ADDISON, TX JANUARY 4, 2024 – SPOTIO, the cutting-edge field sales, and sales engagement software leader, has achieved significant results in G2 Crowd’s Winter 2024 awards, securing an impressive 31 awards. These accolades underscore SPOTIO’s commitment to excellence and innovation in empowering sales teams.

Sales 52

Sales Prospecting Marketing Management 52

Quantified

FEBRUARY 7, 2024

Traditional sales training is hitting a roadblock. It may still provide sound fundamental skills to sales agents new to the profession or your organization, but it’s not designed for a modern workforce or modern buyers requiring individualized approaches. Fortunately, sales AI simulators are ready to fill that gap.

Training 52

Training Sales Sales Management Management 52

PM360

FEBRUARY 22, 2024

Each milestone was pivotal in not only driving recommendations and sales, but also in delivering optimal sun protection for all. Director, Medical Sales & Marketing Vicky Louit Director, Medical Marketing Janet Lyngdal Medical Marketing Brand Manager

Medical sales 52

Medical sales Pharma Media Sales 52

PM360

FEBRUARY 8, 2024

Elevate Healthcare and LivaNova USA, Inc. VNS Therapy is a Life-changer VNS (vagus nerve stimulation) Therapy is designed for people living with seizures despite trying multiple medications. The campaign helped showcase the ability of VNS patients to experience improved quality of life by illustrating everyday activities.

Pharma 52

Pharma Sales Management Healthcare 52

Spotio

JANUARY 23, 2024

Dallas, TX – January 23, 2024 – SPOTIO, the leader in field sales engagement technology, and Solo, the all-in-one solar growth and proposal platform, are excited to announce an enhanced native integration that will redefine efficiency and effectiveness in the solar sales sector.

Sales experience 52

Sales experience Sales Leads Engineering 52

PM360

FEBRUARY 23, 2024

RevHealth for Corium OZURDEX® Interactive Sales Aid We tackled this on two fronts. The first was a total redesign to modernize our look and feel and develop clean layouts. The second was ensuring UI and content delivered an intuitive experience. CONGRATULATIONS TO THE ENTIRE REVHEALTH TEAM

Pharma 52

Pharma Sales 52

PharmaVoice

APRIL 17, 2024

As the cliffs approach, pharma companies are tackling the sales hit with diverging strategies.

Pharma 59

Pharma Sales 59

Spotio

NOVEMBER 20, 2023

This sales model has many different advantages. At the end of the day, distributors simplify the sales process for manufacturers. Others use specific methods to ensure more sales. In other words, you need to select sales channels for yourself and/or your sales team. Why Sell To Distributors?

Retail 52

Retail Distribution Sales Manufacturing 52

Pharmaceutical Technology

FEBRUARY 8, 2024

Abilify Maintena is approaching a significant market shift with the loss of market exclusivity in Europe and the US in October 2024.

Sales 52

Sales Marketing 52

Contrarian Sales Techniques

DECEMBER 18, 2023

Brace yourselves for a change in your e-commerce experience come January 1st, 2024. The government is rolling out a 10% sales tax on Low Value Goods (LVG) purchased online, affecting platforms like Lazada and Shopee. Attention all Malaysian online shoppers!

Government 40

Government Sales Manufacturing 40

PM360

FEBRUARY 8, 2024

Each milestone was pivotal in not only driving recommendations and sales, but also in delivering optimal sun protection for all. Director, Medical Sales & Marketing Vicky Louit Director, Medical Marketing Janet Lyngdal Medical Marketing Brand Manager

Pharma 52

Pharma Medical sales Management Medical 52

PM360

FEBRUARY 8, 2024

HCP Marketing Production Company: Chief Productions, Kaleida Bronze Winner – RevHealth for Corium OZURDEX® Interactive Sales Aid We tackled this on two fronts. HCP Marketing Kishan Mistry Senior Manager, U.S. The first was a total redesign to modernize our look and feel and develop clean layouts.

Pharma 52

Pharma Marketing Sales Management 52

PM360

DECEMBER 12, 2023

The initial deadline for submissions is February 23, 2024. PM360 will then continue to accept entries until March 15, 2024, but anything after Feb. Established a decade ago, the PM360 ELITE honors 100 of the top individuals and marketing teams across the healthcare and life sciences industries each year.

Education 52

Education Healthcare Healthcare Marketing 52

European Pharmaceutical Review

NOVEMBER 2, 2023

“We do not expect entry of Stelara biosimilars in the United States during 2024,” Joseph Wolk CFO, Johnson & Johnson, stated during the company’s Q3 earnings call on 18 October. However, he did note that Stelara does have a composition of matter patent expiry in mid-2024 in Europe. US sales of Stelara totalled $6.4

Food and Drug Administration 93

Food and Drug Administration FDA Side effects Safety 93